New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.

The number of people poisoned by the incorrect use of weight loss medication is on the rise in the Netherlands. Last year, ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

More people are reporting experiencing potentially dangerous side effects after using slimming drugs, the national toxicology ...

"The medication's going to be 50 percent of your journey, and the other 50 percent is still what you choose to eat and the ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...